Product Images Vecuronium Bromide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Vecuronium Bromide NDC 47335-932 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
vecuronium-carton-10mg - vecuronium carton 10mg
Vecuronium Bromide for Injection is a paralyzing agent that requires facilities for artificial respiration to be immediately available. The drug is available in 10 x 10mg vials of lyophilized powder and contains 1 mg/mL of vecuronium bromide USP when reconstituted to 10mL with sterile water for injection. The solution also includes citric acid anhydrous, dibasic sodium phosphate anhydrous, and mannitol, and has a pH range of 3.5 to 4.5 when necessary adjustments are made with sodium hydroxide and/or phosphoric acid. If the powder has been reconstituted with sterile water for injection or other compatible IV solutions, it must be refrigerated and used within 24 hours, while if bacteriostatic water for injection is used, it should be used within 5 days only. Discard the unused portion, and the storage should be done in a cool place, protected from light. The manufacturer is Sun Pharmaceutical Industries Ltd. from Halol-Baroda Highway, Halol-389 350, Gujarat, India, and the distributor is Sun Pharmaceutical Industries, Inc. from Cranbury, NJ 08512.*
vecuronium-carton-20mg - vecuronium carton 20mg
Vecuronium Bromide for Injection is a lyophilized powder available in packs of 10 vials, weighing 20 mg. When reconstituted with sterile water for injection, the solution contains vecuronium bromide USP of 1 mg/mL, citric acid anhydrous of 2.075 mg/mL, dibasic sodium phosphate anhydrous of 1.625 mg/mL, and mannitol of 9.7 mg/mL. The pH of the solution is adjusted to a range of 3.5 to 4.5 with phosphoric acid and/or sodium hydroxide. Pharmacies and healthcare facilities should be equipped with artificial respiration facilities since the medicine can cause respiratory arrest. The product contains benzyl alcohol, which is not suitable for use in newborns. Compatibility with other IV solutions is permitted, but the solution must be discarded if not used within 24 hours if not refrigerated. Unused product must not be used. The medicine should be kept below 25°C and protected from light. The manufacturing company is Sun Pharmaceutical Ind. Ltd., while the distributor is Sun Pharmaceutical Industries, Inc. The product complies with NDC 47335-932-44.*
vecuronium-chem-str - vecuronium chem str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.